RAYMOND JAMES & ASSOCIATES - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q1 2023$207,433
+6.5%
16,961
+8.1%
0.00%
Q4 2022$194,700
-17.5%
15,689
-9.2%
0.00%
Q3 2022$236,000
-26.7%
17,275
-1.6%
0.00%
Q2 2022$322,000
+13.8%
17,552
-0.3%
0.00%
Q1 2022$283,000
+36.1%
17,598
+18.6%
0.00%
Q4 2021$208,000
-37.7%
14,841
-16.8%
0.00%
Q3 2021$334,000
-12.3%
17,839
-2.5%
0.00%
Q2 2021$381,000
-26.4%
18,291
-0.2%
0.00%
-100.0%
Q1 2021$518,000
-17.8%
18,327
-5.0%
0.00%0.0%
Q4 2020$630,000
+3.1%
19,283
-3.3%
0.00%0.0%
Q3 2020$611,000
+98.4%
19,938
+5.4%
0.00%
Q2 2020$308,000
+79.1%
18,910
+9.4%
0.00%
Q1 2020$172,000
-32.0%
17,282
-6.2%
0.00%
Q4 2019$253,000
-10.6%
18,433
-1.3%
0.00%
Q3 2019$283,000
-23.9%
18,669
-1.2%
0.00%
-100.0%
Q2 2019$372,000
-4.6%
18,895
-19.6%
0.00%0.0%
Q1 2019$390,000
+33.6%
23,490
+12.9%
0.00%0.0%
Q4 2018$292,000
-35.0%
20,814
-18.8%
0.00%0.0%
Q3 2018$449,00025,6380.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders